Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKRO NASDAQ:HEES NYSE:OKLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKROAkero Therapeutics$54.65+0.2%$54.50$37.28▼$57.35$4.50B-0.41.86 million shs15.31 million shsHEESH&E Equipment Services$94.64$94.46$88.87▼$96.45$3.47B1.87639,457 shsN/AOKLOOklo$65.76-0.2%$60.96$43.63▼$193.84$11.44B1.1614.38 million shs11.37 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKROAkero Therapeutics0.00%0.00%0.00%0.00%+17.88%HEESH&E Equipment Services0.00%0.00%0.00%0.00%0.00%OKLOOklo0.00%+5.62%-7.48%+4.00%+33.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKROAkero Therapeutics$54.65+0.2%$54.50$37.28▼$57.35$4.50B-0.41.86 million shs15.31 million shsHEESH&E Equipment Services$94.64$94.46$88.87▼$96.45$3.47B1.87639,457 shsN/AOKLOOklo$65.76-0.2%$60.96$43.63▼$193.84$11.44B1.1614.38 million shs11.37 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKROAkero Therapeutics0.00%0.00%0.00%0.00%+17.88%HEESH&E Equipment Services0.00%0.00%0.00%0.00%0.00%OKLOOklo0.00%+5.62%-7.48%+4.00%+33.90%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKROAkero Therapeutics 2.10Hold$60.8011.25% UpsideHEESH&E Equipment Services 0.00N/AN/AN/AOKLOOklo 2.57Moderate Buy$82.5825.58% UpsideCurrent Analyst Ratings BreakdownLatest AKRO, HEES, and OKLO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026OKLOOklo Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$80.005/22/2026OKLOOklo Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$80.005/19/2026OKLOOklo Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoveragePeer Perform5/14/2026OKLOOklo CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$73.50 ➝ $76.005/13/2026OKLOOklo Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/13/2026OKLOOklo WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$110.005/13/2026OKLOOklo Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$122.005/11/2026OKLOOklo JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$83.004/27/2026OKLOOklo Tigress FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$130.004/23/2026OKLOOklo HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$96.00(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKROAkero TherapeuticsN/AN/AN/AN/A$10.75 per shareN/AHEESH&E Equipment Services$1.46B2.37$14.76 per share6.41$14.66 per share6.46OKLOOkloN/AN/AN/AN/A$15.16 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKROAkero Therapeutics-$252.06M-$1.94N/AN/AN/AN/A-15.86%-14.78%N/AHEESH&E Equipment Services$169.29M$2.4924.0224.58N/A9.47%25.46%5.16%N/AOKLOOklo-$105.66M-$0.84N/AN/AN/AN/A-8.57%-8.30%8/10/2026 (Estimated)Latest AKRO, HEES, and OKLO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026OKLOOklo-$0.20-$0.19+$0.01-$0.19N/AN/A3/17/2026Q4 2025OKLOOklo-$0.17-$0.27-$0.10-$0.27N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAKROAkero TherapeuticsN/AN/AN/AN/AN/AHEESH&E Equipment Services$1.101.16%N/A44.18%N/AOKLOOkloN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKROAkero TherapeuticsN/A15.8415.83HEESH&E Equipment Services2.090.640.59OKLOOkloN/A59.9359.93Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKROAkero TherapeuticsN/AHEESH&E Equipment Services84.08%OKLOOklo85.03%Insider OwnershipCompanyInsider OwnershipAKROAkero Therapeutics7.07%HEESH&E Equipment Services12.50%OKLOOklo18.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKROAkero Therapeutics3082.32 million76.50 millionOptionableHEESH&E Equipment Services2,38036.67 million32.03 millionOptionableOKLOOklo78173.99 million141.11 millionOptionableAKRO, HEES, and OKLO HeadlinesRecent News About These CompaniesIs the TVA-ENTRA1 Project NuScale's Biggest Growth Catalyst Yet?1 hour ago | zacks.comHandelsbanken Fonder AB Makes New $2.56 Million Investment in Oklo Inc. $OKLOMay 25 at 5:01 AM | marketbeat.comPromising Nuclear Stocks To Watch Today - May 21stMay 24 at 5:39 AM | americanbankingnews.comResona Asset Management Co. Ltd. Invests $2.49 Million in Oklo Inc. $OKLOMay 24 at 4:57 AM | marketbeat.comInsider Selling: Oklo (NYSE:OKLO) Insider Sells $612,205.92 in StockMay 24 at 4:55 AM | americanbankingnews.comBofA Securities initiates buy coverage on Oklo with $80 price targetMay 23 at 12:49 AM | cryptobriefing.comCOklo reinstated with buy rating at BofA as potential early leader in small modular reactorsMay 23 at 12:49 AM | msn.comOklo (NYSE:OKLO) Now Covered by Analysts at Bank of AmericaMay 23 at 3:40 AM | americanbankingnews.comOklo (NYSE:OKLO) Trading 1% Higher - What's Next?May 22 at 5:37 PM | marketbeat.comWhy is Oklo stock surging on Wednesday?May 22 at 1:16 PM | msn.comWhy NYSE Composite Gains After Oklo Aurora Reactor Approval?May 22 at 8:15 AM | kalkinemedia.comKLeonteq Securities AG Invests $1.69 Million in Oklo Inc. $OKLOMay 22 at 5:46 AM | marketbeat.comOklo AI Lab Partnership Adds New Angle To Volatile Valuation StoryMay 21, 2026 | finance.yahoo.comOklo (NYSE:OKLO) Shares Up 4% - Still a Buy?May 21, 2026 | marketbeat.comOklo (NYSE:OKLO) Insider William Carroll Murphy Goodwin Sells 10,548 SharesMay 21, 2026 | marketbeat.comCan OKLO's $1.68B Fuel Recycling Push Turn Into a Growth Lever?May 21, 2026 | finance.yahoo.comPrediction: Oklo Stock Will Surge 75% This YearMay 21, 2026 | 247wallst.comPrediction: Oklo Stock Will Surge 75% This YearMay 21, 2026 | 247wallst.comCan OKLO's $1.68B Fuel Recycling Push Turn Into a Growth Lever?May 21, 2026 | zacks.comOklo Inc. $OKLO Stock Position Increased by DNB Asset Management ASMay 21, 2026 | marketbeat.comAI Provides Tailwind for the Next Phase of the Nuclear RenaissanceMay 20, 2026 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026Does Cheesecake Factory Stock Have Any Upside Left on the Menu?By Jennifer Ryan Woods | April 27, 2026Oklo Stock Could Be Ready for Another Massive RunBy Thomas Hughes | May 14, 2026MarketBeat Week in Review – 05/11 - 05/15By MarketBeat Staff | May 16, 2026AKRO, HEES, and OKLO Company DescriptionsAkero Therapeutics NASDAQ:AKROAkero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.H&E Equipment Services NASDAQ:HEESH&E Equipment Services, Inc. engages in the provision of equipment services, which focus on heavy construction and industrial equipment. It operates through the following segments: Equipment Rentals, Sales of Rental Equipment, Sales of New Equipment, and Parts, Service and Other Revenues. The Equipment Rentals segment focuses on renting construction and industrial equipment. The Sales of Rental Equipment segment is generated primarily from sales from the rental fleet. The Sales of New Equipment segment sells equipment through a professional sales force. The Parts, Service and Other Revenues segment provides parts to the own rental fleet and sells parts for the equipment. The company was founded by Tom Engquist and Frank Head in 1961 and is headquartered in Baton Rouge, LA.Oklo NYSE:OKLO$65.76 -0.12 (-0.19%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$65.40 -0.36 (-0.54%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
